This UV Lamp Could Prevent the Flu Virus From Spreading in Public Places

Researchers have developed an ultraviolet (UV) lamp that kills the influenza virus but isn’t harmful to human skin or eyes, according to a new study in Scientific Reports. They hope the technology can be commercialized and marketed to prevent the spread of seasonal flu in public places, such as schools, hospitals, and airports. “We’ve known for a century that UV light is extremely efficient at killing microbes, bacteria, and viruses,” says study leader David Brenner, director of the Center for Radiological Research at Columbia University Irving Medical Center. For that reason, UV devices are often used for sterilization — for medical equipment in hospitals, for example, or drinking water for backcountry campers. But conventional germicidal lamps aren’t safe for humans to be around. With prolonged exposure, they can cause skin cancer and cataracts in the eyes. “So up until now, they’re only really practical when people aren’t around,” say Brenner. “You can sterilize a hospital room, but not when anyone’s inside.” About five years ago, Brenner says, the Columbia team came up with a potential solution. Light on the far end of the UV-C spectrum, known as far-UVC, has very short wavelengths. The researchers suspected that it can penetrate and destroy microscopic bacteria and viruses, but can’t travel through the protective outer layers of human skin or eyes. “We wanted to get all the benefit...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized health healthytime onetime Source Type: news

Related Links:

"The first doctor who saw me told me to go home and die," says a pancreatic cancer survivor who hopes one day no one else will have to hear those words
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
Authors: Koehler LA, Hunter DW Abstract Axillary web syndrome (AWS) is a frequently overlooked problem that causes morbidity in the early post-operative period following cancer surgery with axillary lymph node removal (1-3). AWS, also known as “cording” was first described in 2001 by Moskovitz as “a visible web of axillary skin overlying palpable cords of tissue that are made taut by shoulder abduction” (1). Over a decade has passed since Moskovitz’s seminal article was published, and we still lack a good understanding of AWS. This condition has been suboptimally studied using widely d...
Source: Lymphology - Category: Internal Medicine Tags: Lymphology Source Type: research
Authors: Tam T PMID: 29911817 [PubMed - in process]
Source: Health Promotion and Chronic Disease Prevention in Canada - Category: International Medicine & Public Health Tags: Health Promot Chronic Dis Prev Can Source Type: research
Authors: Skowronski M, Risør MB, Andersen RS, Foss N Abstract Little is known about how people living in the aftermath of cancer treatment experience and manage worries about possible signs of cancer relapse, not as an individual enterprise but as socially embedded management. One-year ethnographic fieldwork was conducted in a coastal village of under 3000 inhabitants in northern Norway. Ten villagers who had undergone cancer treatment from six months to five years earlier were the main informants. During fieldwork, the first author conducted qualitative, semi-structured monthly interviews with them, and par...
Source: Anthropology and Medicine - Category: International Medicine & Public Health Tags: Anthropol Med Source Type: research
It's hard to reach the "hard-to-reach": the challenges of recruiting people who do not access preventative healthcare services into interview studies. Int J Qual Stud Health Well-being. 2018 Dec;13(1):1479582 Authors: Rockliffe L, Chorley AJ, Marlow LAV, Forster AS Abstract In this article, we discuss the challenges faced in recruiting "hard-to-reach" groups for interview studies, specifically those who do not access preventative healthcare services. We do this by reflecting on the varying success of different recruitment methods we have used in two recent studies; one investigating...
Source: International Journal of Qualitative Studies on Health and Well-being - Category: International Medicine & Public Health Tags: Int J Qual Stud Health Well-being Source Type: research
Provisional vaccine guidelines for people with autoimmune inflammatory rheumatic disease are in the final stages of review and will be released later this year.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. Minerva Chir. 2018 Jun;73(3):288-294 Authors: Belcaro G, Dugall M, Cotellese R, Feragalli B, Cianchetti E, Cesarone MR Abstract BACKGROUND: Post-mastectomy lymphedema is one of the most significant, non-life-threatening complications following breast cancer surgery and radiotherapy. Post-mastectomy post-radiotherapy (PMPR) lymphedema is related to damages to lymphatics and/or veins during/after axillary surgery and radiotherapy. The management of this condition is very challenging; the comprehensive decongestive therapy...
Source: Minerva Chirurgica - Category: Surgery Tags: Minerva Chir Source Type: research
NEW YORK (CBS Local/CBS News) – Smoking in the U.S. has hit another all-time low. About 14 percent of U.S adults admit to being smokers last year, down from about 16 percent in 2016, government figures from the CDC show. There hadn’t been much change the previous two years, but it’s been clear there’s been a general decline and the new figures show it’s continuing, according to K. Michael Cummings of the tobacco research program at Medical University of South Carolina. “Everything is pointed in the right direction,” including falling cigarette sales and other indicators, Cummi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Local TV Smoking talkers Source Type: news
The science is clear: Drinking too much alcohol is bad for your health, but exactly how low-risk is light drinking?
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Nat. Prod. Rep., 2018, Advance Article DOI: 10.1039/C8NP00013A, Review ArticleMichael[space]W. Mullowney, Ryan A. McClure, Matthew T. Robey, Neil L. Kelleher, Regan J. Thomson Thioester reductases arm natural products, such as the peptide aldehydes and the anti-cancer drug Yondelis, with unique structures and bioactivity. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Nat. Prod. Rep. latest articles - Category: Chemistry Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cataract Removal | Cataracts | Epidemics | Epidemiology | Eyes | H1N1 | Health | Hospitals | Infectious Diseases | Influenza | Influenza Vaccine | Medical Devices | MRSA | Schools | Skin | Skin Cancer | Study | Superbugs | Swine Flu (H1N1) Vaccine | Vaccines | Veterinary Vaccinations